Sangamo Therapeutics
SGMO
#6403
Rank
โ‚ฌ0.54 B
Marketcap
2,61ย โ‚ฌ
Share price
13.77%
Change (1 day)
563.59%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -1,34ย โ‚ฌ

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,34ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,16ย โ‚ฌ a decrease over its 2021 EPS that were of -1,15ย โ‚ฌ.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,34ย โ‚ฌ15.92%
2022-1,16ย โ‚ฌ0.81%
2021-1,15ย โ‚ฌ33.33%
2020-0,86ย โ‚ฌ6.9%
2019-0,81ย โ‚ฌ22.54%
2018-0,66ย โ‚ฌ1.43%
2017-0,65ย โ‚ฌ-31.37%
2016-0,95ย โ‚ฌ75.86%
2015-0,54ย โ‚ฌ48.72%
2014-0,36ย โ‚ฌ-17.02%
2013-0,44ย โ‚ฌ9.3%
2012-0,40ย โ‚ฌ-39.44%
2011-0,66ย โ‚ฌ29.09%
2010-0,51ย โ‚ฌ22.22%
2009-0,42ย โ‚ฌ-25%
2008-0,56ย โ‚ฌ3.45%
2007-0,54ย โ‚ฌ5.45%
2006-0,51ย โ‚ฌ10%
2005-0,46ย โ‚ฌ-9.09%
2004-0,51ย โ‚ฌ30.95%
2003-0,39ย โ‚ฌ-65.29%
2002-1,12ย โ‚ฌ15.24%
2001-0,97ย โ‚ฌ3.96%
2000-0,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
4,07ย โ‚ฌ-404.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,81ย โ‚ฌ 185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
13,12ย โ‚ฌ-1,082.64%๐Ÿ‡บ๐Ÿ‡ธ USA
17,12ย โ‚ฌ-1,381.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1,71ย โ‚ฌ-227.78%๐Ÿ‡บ๐Ÿ‡ธ USA
13,06ย โ‚ฌ-1,078.15%๐Ÿ‡บ๐Ÿ‡ธ USA
0,72ย โ‚ฌ-154.07%๐Ÿ‡บ๐Ÿ‡ธ USA
1,69ย โ‚ฌ-226.51%๐Ÿ‡บ๐Ÿ‡ธ USA